Utility of EUS-FNA and Cyst Fluid Analysis in the Diagnosis of Pancreatic Cysts: Correlation with Histopathology in 51 Patients

2006 ◽  
Vol 63 (5) ◽  
pp. AB278 ◽  
Author(s):  
Siriboon Attasaranya ◽  
Shireen A. Pais ◽  
Julia K. Leblanc ◽  
Stuart Sherman ◽  
Lee Mchenry ◽  
...  
2016 ◽  
Vol 111 ◽  
pp. S31
Author(s):  
Enqiang Linghu ◽  
Wei Zhang ◽  
Zhiqiang Wang ◽  
Xiangdong Wang ◽  
Ping Tang ◽  
...  

2004 ◽  
Vol 31 (2) ◽  
pp. 100-105 ◽  
Author(s):  
Ji Kon Ryu ◽  
Sang Myung Woo ◽  
Jin-Hyeok Hwang ◽  
Ji Bong Jeong ◽  
Yong Bum Yoon ◽  
...  

2012 ◽  
Vol 142 (5) ◽  
pp. S-852
Author(s):  
Disha Mahendra ◽  
Srinivas Gaddam ◽  
Dayna S. Early ◽  
Daniel Mullady ◽  
Riad R. Azar ◽  
...  

2014 ◽  
Vol 122 (11) ◽  
pp. 804-809 ◽  
Author(s):  
Ivan Chebib ◽  
Kurt Yaeger ◽  
Mari Mino-Kenudson ◽  
Martha B. Pitman

1992 ◽  
Vol 38 (8) ◽  
pp. 1501-1503 ◽  
Author(s):  
M R Pins ◽  
C C Compton ◽  
J F Southern ◽  
D W Rattner ◽  
K B Lewandrowski

Abstract Pancreatic cysts include inflammatory pseudocysts, cystic tumors (serous and mucinous), and various rare cystic lesions. We report a case of a ciliated enteric duplication cyst that presented on computed tomographic scan as a pancreatic cystic neoplasm. Cyst fluid analysis revealed markedly increased concentrations of carcinoembryonic antigen and CA 125 and increased fluid viscosity. These features are typical for a mucinous cystic neoplasm of the pancreas and demonstrate a potential pitfall associated with the diagnosis of pancreatic cysts by chemical analyses. Enteric duplications involving the pancreas are rare, usually of gastric origin, and usually communicate with their enteric source. Morphological and histochemical analysis suggest that this cyst was of caudal foregut origin. This is the first reported case of a ciliated foregut cyst involving the pancreas. The chemical characteristics of the cyst fluid of these lesions have not been described previously.


2019 ◽  
Vol 144 (1) ◽  
pp. 47-61 ◽  
Author(s):  
Amrou Abdelkader ◽  
Bryan Hunt ◽  
Christopher P. Hartley ◽  
Nicole C. Panarelli ◽  
Tamara Giorgadze

Context.— Pancreatic cystic lesions (PCLs) are very common, and their detection is increasing with the advances in imaging techniques. Because of the major implications for management, distinguishing between neoplastic and nonneoplastic PCLs is critical. Neoplastic cysts with potential to progress into cancer include mucinous PCLs (intraductal papillary mucinous neoplasms and mucinous cystic neoplasms) and nonmucinous cysts (solid pseudopapillary tumors, serous cystic neoplasms, and neuroendocrine tumors with cystic degeneration). Nonneoplastic cysts with no risk of malignant transformation include pseudocysts, retention cysts, lymphoepithelial cysts, cystic pancreatic lymphangioma, and duplication cyst/ciliated foregut cysts. The role of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology with cyst fluid analysis in the diagnosis of PCLs has evolved during the last decade; however, a definitive diagnosis on cytologic specimens is hampered by the sparse cellularity and can be challenging. EUS-FNA can play an important role to differentiate low-risk from high-risk pancreatic cysts and to distinguish between patients with cysts who need clinical follow-up versus those who require surgery. Objective.— To provide an integrative approach to diagnose pancreatic cystic lesions using EUS-FNA cytology and cyst fluid analysis, along with clinical, radiologic, histologic, genetic, and molecular characteristics. Data Sources.— The review and analysis of the latest literature describing pancreatic cystic lesions. Conclusions.— Accurate diagnosis of PCLs requires a multidisciplinary and multimodal team approach, including the integration of clinical findings, imaging, cytology, cyst fluid analysis, and molecular testing.


2018 ◽  
Vol 06 (12) ◽  
pp. E1423-E1430 ◽  
Author(s):  
Dennis Yang ◽  
Jason Samarasena ◽  
Laith Jamil ◽  
Kenneth Chang ◽  
David Lee ◽  
...  

Abstract Background and study aims Accurate diagnosis and classification of pancreatic cysts (PCs) remains a challenge. The aims of this study were to: (1) evaluate the safety and technical success of a novel microforceps for EUS-guided through-the-needle biopsy (TTNB) of PCs; and (2) assess its diagnostic yield for mucinous PCs when compared to FNA cyst fluid analysis and cytology. Patients and methods This was a multicenter retrospective analysis of 47 patients who underwent EUS-FNA and TTNB for PCs between January 2014 and June 2017. Technical success was defined as acquisition of a specimen adequate for cytologic or histological evaluation. Cyst fluid carcinoembryonic antigen (CEA) was used to initially categorize cysts as non-mucinous (CEA < 192 ng/mL) or mucinous (CEA ≥ 192 ng/mL). Final diagnosis was based on identifiable mucinous pancreatic cystic epithelium on cytology, microforceps histology and/or surgical histology when available. Results Forty-seven patients with PCs (mean size 30.7 mm) were included. TTNB was successfully performed in 46 of 47 (97.9 %). Technical success was significantly lower with FNA (48.9 %) compared to TTNB (85.1 %) (P < .001). For cysts with insufficient amount of fluid for CEA (n = 19) or CEA < 192 ng/mL, the cumulative incremental diagnostic yield of a mucinous PC was significantly higher with TTNB vs. FNA (52.6 % vs 18.4 %; P = .004). TTNB alone (34.4 %) diagnosed more mucinous PCs than either CEA ≥ 192 ng/mL alone (6.3 %) or when combined with FNA cytology (9.4 %). One episode of self-limited bleeding (2.1 %) and one of pancreatitis (2.1 %) occurred. Conclusions EUS-TTNB is safe and effective for evaluating PCs. TTNB may help increase the diagnostic yield of mucinous PCs.


Sign in / Sign up

Export Citation Format

Share Document